Kamis, 28 September 2017

Leaders inside the Drug Repositioning and Repurposing subject to meet for sixth Annual Drug Repositioning convention in Chicago in June 2017

Leaders inside the Drug Repositioning and Repurposing subject to meet for sixth Annual Drug Repositioning convention in Chicago in June 2017-

Leaders inside the Drug Repositioning and Repurposing subject to meet for sixth Annual Drug Repositioning convention in Chicago in June 2017


Alzheimer's: Can a difficult job and prepare hold the situation at bay?

Breast most cancers deaths have dropped in lots of international areas

inner radiation remedy: elevated response in metastatic colorectal most cancers sufferers

Axial spondyloarthritis: sufferers see sustained revenue with certolizumab pegol

Rheumatoid arthritis sufferers expertise prolonged-time period advantages with new drug

benefit Healthcare India 2017, Oct. 12 - 14, 2017 at Bengaluru, India




Arrowhead Publishers is comfortable to announce that the sixth Annual Drug Repositioning, Repurposing and Rescue convention will possible be taking place June 27-28, 2017 in Chicago, IL. This event will current a platform for a quantity of stakeholders furthering drug development by a quantity of collaborations, collectively with affected person advocacy efforts and enterprise/educational/authorities cooperation. For extra information, go to: www.drugrepositioningconference.com/brochure.


This 12 months's convention will possible be centered on using repurposing to get hold of and develop new therapies for unusual illnesses. a quantity of key themes at this event will embody:


  • affected person Advocacy Efforts: Emphasis on and engagement with affected person advocacy teams, who're investigating in drug repositioning efforts to an unprecedented diploma
  • New Partnerships: The convention will discover how new partnerships between numerous teams, collectively with authorities, enterprise and academia are teaming as a lot as advance repurposing efforts
  • industrial Case research: Leaders in drug repositioning will discuss about their successes, failures and the best method forward
  • Collaborative efforts: authorities/educational/enterprise collaborations will possible be explored and highlighted in an effort to get hold of out how disparate teams can obtain success
  • Systematic Repositioning and information Analytics: Repurposing is not primarily based on serendipity as more and more extra firms are designing devices to streamline and enhance the percentages of success

Featured audio system embody:


  • Ronald Alfa, MD, Ph.D., vp, Discovery and Product, Recursion prescribed medicine
  • Bobbie Ann Austin, Ph.D., Program Officer, Drug development Partnership functions, nationwide coronary heart for Advancing Translational Sciences (NCATS), office of the Director, nationwide Institutes of well being
  • Pieter Dylst, Senior supervisor Market entry and worth Added Medicines, Medicines for Europe
  • Laura Kleiman, Ph.D., Scientific evaluation Director, cBio coronary heart, Dana-Farber most cancers Institute
  • Daphna Laifenfeld, Ph.D., Sr. Director, personalised & Predictive medicine, Teva Pharmaceutical Industries
  • Kevin Pan, Ph.D., Chief authorities Officer, Asieris prescribed medicine
  • Aris Persidis, Ph.D., President, Biovista
  • Michael Pollastri, Ph.D., affiliate Professor & Chair, Northeastern college, faculty of Science
  • Vidula Sukhatme, Founder and CEO, world Cures

Please go to www.drugrepositioningconference.com/audio system for the complete talking faculty.


For extra information, please contact:


John Waslif: Managing Director, Arrowhead Publishers 866-945-0263 ext seven-hundred, john.waslif@arrowheadpublishers.com


Rachel Donlon: advertising affiliate, Arrowhead Publishers 866-945-0263 ext 701, rachel.donlon@arrowheadpublishers.com







Click to comment